Member Info for JustHereForHemo

CJ, lets call it like it is.
You spent too much time listening to someone who professed to be an expert in all things Hemo and with an inside ear who clearly burnt all bridges and is now as far outside and stuck on Dukemount Island with no ferry in sight. I too listened to all the early chat from him about Orgs working with the Israeli DoD, vlad in talks with the US DoD over disease x.... blah blah blah... Bottom line is yes those talks might have happened, yes Orgs may well be a big deal for Hemo in the next year. SO WHAT?
Your stuck in 6-9 months ago with this god complex to make yourself look or feel important trying to say little (because you actually know sweet FA) but in a way to make yourself sound mysterious and as if you know more than your are letting on. Get real, you dont, you are 3 steps removed from stale information.

Hemogenyx are moving forward, todays RNS is the clearest indication to date that they are preparing the treatments for human trials with doner cells to be treated and grown for re-infusion, if you cannot read that and see the significance because your held up on some song sung into your ear by a nobody then fair enough, move along. But seriously you have zero respect here, to say your transparent is an understatement. Go and actually do some research yourself, ring directors in small MCap yourself and stop sitting there fluffing yourself up, its embarrassing to watch.

Copy and paste below, not a US SPAC, listed only about a week or so XMas eve:

Being small and new is exactly the idea.

Float as PNPL small MCap
Target a much bigger private company, agree terms
Suspend trading, issue of equity to the private company so that they are majority stakeholders.
Resume trading under new trading name.
Make the new larger company target for take over, wait for that to happen and walk away rich.
The relatively small cash pot is to fund the RTO and leave a little sweetener for the RTO target, an extra bit of investment should it be needed. But the Company, without the money, the clean, string free, no issue shell called Pineapple Power IS the asset being sold, and there are plenty of private companies who will jump at the opportunity to use it to get a public listing.

Hi Darling, let me guess a re-incarnation of a banned account, please put a little more effort into de-ramping attempts, that is really sad and pathetic :-D

the entire market is down, lockdown + recession threat.
Dont sweat it, the government will be pumping cash into green, companies like this will explode, esp considering they are a cash shell, they have no expenses or physical presence, so there is no impact from lock down on them.

Warm fuzzy feeling from the video, whilst no new inside info(not expected), it gives confidence + the SP is down today, whats not to like. Limited funds so not as much as I would like but in for a small holding today :-)

what is with this market today? you would think we were going under lockdown again or another recession or something like that....

Really non event the fact we are red right now, not nice but lets face it, the people who sold were going to sell no matter what the RNS was, if it was an RNS stating they have decided to change supplier for the mouse food the traders would have sold. I am dissapointed however that people have gotten so fixated on this one Eli Lilly licencing contract and are missing everything else that is going on. People should realise, Eli are going to give hemo millions yes, but they will own CDX and only give Hemo probably < 20% of the revenues... Right now Hemo own 100% of the CAR-T work thats about to go to clinical trials. This is a big deal and you could easily see a massive licencing deal for CAR-T within the first half of 2021 worth multiples of anything Eli pay, its a much bigger deal.

But the market is obsessed with Eli, so fine, its still coming, but dont expect Vlad to stop everything else just to wait for Eli.

Digittt, I expected an RNS adding SAFE to Penn back in December, and then a separate one stating going forward to clinical trials, they have combined both, saves some money on RNS ;-)
Its completely separate to the CDX licencing agreement that should be due soon.

Dave, there are purely binary investors who will sell on news, no matter what that news is, they waited for a RNS, got one, didnt bother reading it, sold. The reason why so many lose money on the stock market, they are idiots. Its a good RNS though, it indicates we should see the first patient actually get injected with CAR-T within Q1 hopefully, sounds very gung-ho re clinical trials.

The wording of the agreement is not totally clear, they have retained Penn to include:
i. vector manufacturing for the delivery of HEMO-CAR-T to the patient's T-cells;
ii. an investigational new drug ("IND") filing for permission to conduct clinical trials; and
iii. clinical manufacturing of patient-specific HEMO-CAR programmed T-cells

So am I right in assuming they are going to start now manufacturing CAR-T cells before even the 30 day window is complete? I thought that would be part of the clinical trial stage and that would be announced AFTER the IND application?

This RNS could be signalling clinical trials within next 2 months!

and there we go :-)

Looks like MMs about to print SP as 9.8, expect blue very very soon :P

The Development Agreement ended 31st December 2020. Eli Lilly now have 3 months to licence, likely sooner rather than later.
And no, most LTH'ers are fully used to the lack of communication and none of us expected an RNS on 31st or even the first day back of trading, Hemo never works like that, the RNS will catch us all by surprise it wont be telegramed in advance

I would stick to MUST and REAT pumpkin

Dont bother with Pineapple, will be good eventually but they cannot do anything for some time, it will be weeks maybe even months there before they can RNS or even hint at the RTO target. It will stagnate, best to sell now, take your profit and stick with must, they could RTO any day.

I have said nothing on MUST to try and deflate your 22% gain over there on the directors buy but more than happy to if you want to start spamming here?
You know how I feel about that company and you will also be only too aware they have ZERO targets for the immediate future, but its your call if you want us to visit there? personally I could not be bothered but if you want to start being an idiot here happy to oblige?

I really dont care if you want to pump away at MUST and bag yourself a bag there, I really dont give a damn, I am not invested in must and never will, its what normal sane people do, not waste time on shares they are not invested in.

Mr 49,888 is a LTH who holds millions and likes to use the last 3 characters 888 as his signature and as a lucky number.
Chatted to him this morning and confirmed it was him.

Mr 49,888 buyer is back, and yes he is a buyer.

No placing and they are not making multiple investments. This is a cash shell.
Within a few months RTO with a target that is already generating a revenue and not in need of a huge cash injection, the 1.3m will be more than enough for Pineapple Power.

Just checking in, morning all, end of the development agreement now its anybodys guess on what day we get news. Pretty sure everyone with half a brain has been saying of all days today was the one day when update was NOT expected. Looking forward to 2021 :-)
Happy New year's everyone, switch off and come back Monday!

They started this journey together years ago and it was only when the labs reopened and Eli started work to select the best antibody did they fix a date of tomorrow to complete the working agreement.
Walking away from the antibody at this point would be a spectacular waste of time, money and resources. I won't say its guaranteed but pretty damn close!

I see 2 possibilities, in both they sign a licencing agreement to lock in CDX exclusivity and maintain the competitive advantage they are currently entitled to.
1, They take on CDX as it stands, decent up front, good milestones and revenues agreed. The best case and most likely scenario imo.
2, The offer is initially sub par and rejected, they agree to generous milestone payments and revenues but without large upfront cash, basically they agree to fund the clinical trials but nothing extra UNTIL its proven in phase 1/2a stage.

But like I say, no licence for me is just not realistic, well past that point, it's all down to the money now.